(Stroke. 1995;26:1825-1829.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Radiology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Correspondence to Yasuo Kuwabara, MD, Department of Radiology, Faculty of Medicine, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-82, Japan.
Background and Purpose The acetazolamide effect is thought to reach a maximum at 10 to 20 minutes after administration. However, we sometimes encountered patients who showed a transient deterioration of ischemic symptoms several minutes after acetazolamide administration. We therefore considered that a steal phenomenon may occur before the acetazolamide effect reaches a maximum. We evaluated the time dependency of the acetazolamide effect on cerebral hemodynamics in patients with severe stenosis or occlusion of the unilateral internal carotid artery.
Methods The subjects consisted of 13 patients with severe stenosis or occlusion of the unilateral internal carotid artery. Regional cerebral blood flow was measured at the resting state and at 5 and 20 minutes after the intravenous administration of 1 g acetazolamide by the use of the [15O]H2O bolus-injection method and positron emission tomography. The steal phenomenon was interpreted as positive when the regional cerebral blood flow values decreased by more than 10% after the administration of acetazolamide in more than one region of interest.
Results A steal phenomenon was observed in 5 of 13 patients at 5 minutes after acetazolamide administration on the occlusive side, whereas it was observed in only 1 patient at 20 minutes. Thus, this phenomenon was observed more frequently in the early phase of the acetazolamide test. It was also observed more frequently in patients with poorly developed collateral circulation.
Conclusions Our acetazolamide [15O]H2O positron emission tomography study revealed an early steal phenomenon at 5 minutes after intravenous administration of acetazolamide, which may be a cause of the transient deterioration of ischemic symptoms during the acetazolamide test.
Key Words: acetazolamide carotid stenosis cerebral blood flow tomography, emission-computed
This article has been cited by other articles:
![]() |
N. Mori, S. Mugikura, S. Higano, T. Kaneta, M. Fujimura, A. Umetsu, T. Murata, and S. Takahashi The Leptomeningeal "Ivy Sign" on Fluid-Attenuated Inversion Recovery MR Imaging in Moyamoya Disease: A Sign of Decreased Cerebral Vascular Reserve? AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 930 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Weber, G. Westera, V. Treyer, C. Burger, N. Khan, and A. Buck Constant-Infusion H215O PET and Acetazolamide Challenge in the Assessment of Cerebral Perfusion Status J. Nucl. Med., August 1, 2004; 45(8): 1344 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Murakami, T. Yonehara, A. Takaki, S. Fujioka, T. Hirano, and Y. Ushio Evaluation of Delayed Appearance of Acetazolamide Effect in Patients with Chronic Cerebrovascular Ischemic Disease: Feasibility and Usefulness of SPECT Method Using Triple Injection of ECD J. Nucl. Med., May 1, 2002; 43(5): 577 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Silvestrini, F. Vernieri, P. Pasqualetti, M. Matteis, F. Passarelli, E. Troisi, and C. Caltagirone Impaired Cerebral Vasoreactivity and Risk of Stroke in Patients With Asymptomatic Carotid Artery Stenosis JAMA, April 26, 2000; 283(16): 2122 - 2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Ulrich, S. Kroppenstedt, A. Heimann, O. Kempski, and B. G. Lyeth Laser-Doppler Scanning of Local Cerebral Blood Flow and Reserve Capacity and Testing of Motor and Memory Functions in a Chronic 2-Vessel Occlusion Model in Rats • Editorial Comment Stroke, November 1, 1998; 29(11): 2412 - 2420. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Silvestrini, E. Troisi, M. Matteis, L. M. Cupini, and C. Caltagirone Transcranial Doppler Assessment of Cerebrovascular Reactivity in Symptomatic and Asymptomatic Severe Carotid Stenosis Stroke, November 1, 1996; 27(11): 1970 - 1973. [Abstract] [Full Text] |
||||
![]() |
K. Kazumata, N. Tanaka, T. Ishikawa, S. Kuroda, K. Houkin, and K. Mitsumori Dissociation of Vasoreactivity to Acetazolamide and Hypercapnia: Comparative Study in Patients With Chronic Occlusive Major Cerebral Artery Disease Stroke, November 1, 1996; 27(11): 2052 - 2058. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |